PTPRC and metastatic malignant neoplasm: Using this method, blood is taken from subjects with metastatic cancer, processed by exclusion of CD45 + cells and capturing of EpCAM + cells in the VERSA, and stained for Hoechst, cytokeratin, and exclusion markers (CD11b, CD45, CD14, CD34).